We’re always interested in working with new investment firms.
Inozyme Pharma is backed by a syndicate of premier life sciences investors, including:
Longitude Capital
Longitude Capital specializes in making venture growth investments in biotechnology and medical technology companies that seek to improve clinical outcomes, enhance quality of life and/or reduce system costs.
Learn More
New Enterprise Associates
NEA invests in visionary entrepreneurs that are at the helm of current and future industry leaders, fueling the development of technologies that will keep the U.S. at the forefront of innovation.
Learn More
Novo Holdings
Working out of Copenhagen, with affiliates in San Francisco and Boston, Novo Holdings is a world-leading life science investor with a focus on creating long-term value. Novo Holdings invests the wealth of the Foundation in life science investments, which includes investing in life science companies at all stages of development and financial investments, which manages a diversified portfolio of equity and fixed income securities.
Learn More
Pivotal bioVenture Partners
Pivotal bioVenture Partners is a $300 million life sciences venture capital fund established in 2017. Pivotal invests in privately held North American and European companies focused on innovative therapeutic products and platforms to address major unmet medical needs. The company invests at all stages in a company’s evolution, from company creation through mid and late stage clinical development. The Pivotal team brings diverse experience in venture capital, company building, and drug discovery and development to the table in working with entrepreneurs to advance their businesses.
Learn More
Sofinnova
Sofinnova is a clinical-stage biopharmaceutical investment firm with approximately $1.8B in assets under management and committed capital. Sofinnova invests in both private and public equity of therapeutics-focused companies. Learn More
RA Capital Management
RA Capital Management is a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare and life science companies that are developing drugs, medical devices, and diagnostics. The flexibility of its strategy allows RA Capital to provide seed funding to startups and to lead private, IPO, and follow-on financings for its portfolio companies, both facilitating the crossover process and allowing management teams to drive value creation with fewer capital concerns from inception through commercialization.
Learn More
Cowen Healthcare Investments
Cowen Healthcare Investments is dedicated to investing in innovative biotechnology companies that have the potential to transform patient outcomes and reduce healthcare costs.
Learn More
Rock Springs Capital
Rock Springs invests primarily in public and private companies across all subsectors of health care, with a focus on identifying innovative solutions for critical unmet needs.
Learn More
Sanofi Ventures
Sanofi Ventures invests in early-stage biotech and digital health companies with innovative ideas and transformative new projects of strategic interest to Sanofi.
Learn More